Table 1 Basic clinical characteristics of the study subjects ( )
| Â | Control (n = 65) | ACS (n = 65) | P-Value |
|---|---|---|---|
Gender, male/female | 39/26 | 38/27 | 0.542 |
Smoker, (n) (% of the total) | 28 (43.1) | 31 (47.7) | 0.493 |
Age (years) | 65.2 ± 10.2 | 64.8 ± 12.1 | 0.419 |
Systolic blood pressure (mmHg) | 120.7 ± 14.2 | 123.4 ± 14.1 | 0.208 |
Diastolic blood pressure (mmHg) | 74.6 ± 10.2 | 70.8 ± 7.4 | 0.285 |
TG (mmol/L) | 1.8 ± 1.0 | 1.5 ± 1.0 | 0.390 |
TC (mmol/L) | 4.4 ± 0.6 | 4.0 ± 0.8 | 0.154 |
HDL-C (mmol/L) | 1.0 ± 0.3 | 0.9 ± 0.3 | 0.067 |
LDL-C (mmol/L) | 2.6 ± 0.7 | 2.4 ± 0.8 | 0.265 |
Cr (μmol/L) | 74.9 ± 17.0 | 82.7 ± 14.8 | 0.489 |
CK (U/L) | 169.2 ± 21.1 | 207.3 ± 30.3a | 0.038 |
CK-Mb (U/L) | 13.5 ± 5.6 | 38.6 ± 43.0a | 0.001 |
cTnT (ng/mL) | 4.7 ± 4.5 | 795.7 ± 287.1a | 0.000 |
FBS (mmol/L) | 5.1 ± 0.9 | 5.3 ± 1.4 | 0.101 |
WBC (×109/L) | 6.9 ± 1.1 | 7.5 ± 2.4a | 0.028 |
Hb (g/L) | 123.0 ± 9.0 | 118.0 ± 13.0 | 0.347 |
BMI (Kg/m2) | 22.8 ± 2.4 | 23.9 ± 3.0 | 0.086 |
h-CRP (mg/L) | 1.3 ± 0.9 | 5.6 ± 4.1a | 0.001 |
Medication history, n (%) | Â | Â | Â |
ACEI/ARB | NE | 15 (23.0) | - |
β- blocker | NE | 24 (36.9) | - |
Statin | NE | 30 (46.2) | - |
CCB | NE | 32 (49.2) | - |
Insulin | NE | 2 (3.0) | - |